Jacobs, S., Robidoux, A., Abraham, J., Perez-Garcia, J., La Verde, N., Orcutt, J., . . . Pogue-Geile, K. (2019). NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2(+) breast cancer.
Citación estilo ChicagoJacobs, SA, et al. NSABP FB-7: A Phase II Randomized Neoadjuvant Trial With Paclitaxel + Trastuzumab And/or Neratinib Followed By Chemotherapy and Postoperative Trastuzumab in HER2(+) Breast Cancer. 2019.
Cita MLAJacobs, SA, et al. NSABP FB-7: A Phase II Randomized Neoadjuvant Trial With Paclitaxel + Trastuzumab And/or Neratinib Followed By Chemotherapy and Postoperative Trastuzumab in HER2(+) Breast Cancer. 2019.
Precaución: Estas citas no son 100% exactas.